Skip to main content
Tofflon Science and Technology Group Co.,Ltd. logo

Tofflon Science and Technology Group Co.,Ltd. — Investor Relations & Filings

Ticker · 300171 ISIN · CNE100000ZP0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,509 across all filing types
Latest filing 2016-03-01 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300171

About Tofflon Science and Technology Group Co.,Ltd.

https://www.tofflon.com

Tofflon Science and Technology Group Co.,Ltd. is a comprehensive service provider specializing in pharmaceutical equipment and integrated engineering solutions. The company focuses on the research, development, and manufacturing of advanced systems for the life science and pharmaceutical industries. Its core product portfolio includes lyophilization systems, aseptic filling lines, pharmaceutical water systems, and bioprocessing equipment. Tofflon provides end-to-end solutions ranging from laboratory-scale research tools to large-scale commercial production lines, incorporating automation and digitalization to support smart factory initiatives. Key offerings include freeze-dryers, isolator systems, and liquid processing equipment designed to meet global regulatory standards. By integrating process knowledge with engineering expertise, the group supports the production of vaccines, biologicals, and chemical drugs for a global client base.

Recent filings

Filing Released Lang Actions
关于使用超募资金收购驭发制药40%股权的可行性报告
Capital/Financing Update Classification · 95% confidence The document is a detailed feasibility report regarding the use of surplus funds to acquire 40% equity in a subsidiary company, Shanghai Yufa Pharmaceutical Equipment Co., Ltd. It includes company background, shareholder structure, financial data from audit reports, asset evaluations, business performance, acquisition plan, transaction details, funding sources, impact analysis, implementation schedule, risk assessment, and conclusion. The content focuses on a capital acquisition transaction and its strategic implications rather than a general financial report, earnings release, or regulatory announcement. It is not a full annual or interim report, nor a simple announcement or certification. The document is a comprehensive capital/financing update related to a specific equity acquisition using surplus funds, fitting the Capital/Financing Update (CAP) category.
2016-03-01 Chinese
关于使用部分超募资金购买低风险保本型理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Shanghai Dongfulong Technology Co., Ltd. regarding the use of part of its over-raised funds to purchase low-risk principal-protected financial products. It references regulatory guidelines on the management and use of raised funds, details the amount of over-raised funds, previous uses of such funds, and the decision-making process including board and supervisory committee approvals. The document includes independent directors' opinions and the sponsor's verification opinion, confirming compliance with relevant regulations. The content is focused on a specific capital/financing update related to the use of over-raised funds for investment purposes, rather than a full financial report or earnings release. The document length is about 4,868 characters, which is substantial and contains detailed information about the financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2016-03-01 Chinese
招商证券股份有限公司关于公司使用部分超募资金购买低风险保本型理财产品的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the use of excess raised funds by Shanghai Dongfulong Technology Co., Ltd. to purchase low-risk capital-protected financial products. It includes extensive information about the fundraising, use of excess funds, investment purpose, risk analysis, decision procedures, and the sponsor's opinion. The document references regulatory rules and approvals, and it is a formal verification or audit opinion related to the use of funds rather than a full annual or interim financial report. It does not contain comprehensive financial statements or quarterly results but focuses on compliance and audit of specific fund usage. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is 4347 characters, which is substantial and contains detailed audit-related content, not just an announcement or certification. Hence, the classification is AR with high confidence. Q1 2016
2016-03-01 Chinese
第三届监事会第十八次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of Shanghai Dongfulong Technology Co., Ltd. It details decisions on the use of surplus funds for acquisition and investment in low-risk financial products, including voting results. The document is not a full financial report, earnings release, or management discussion, but rather a formal disclosure of board/supervisory committee decisions and approvals. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is also not a regulatory filing or report publication announcement since it contains substantive content about board resolutions. The best fitting category is 'Board/Management Information (MANG)' as it relates to decisions made by the company's supervisory board and management-level approvals.
2016-03-01 Chinese
独立董事对第三届董事会第十九次（临时）会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Shanghai Dongfulong Technology Co., Ltd. regarding the use of over-raised funds for acquiring a 40% stake in another company and for purchasing low-risk capital-protected financial products. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses compliance with fundraising and fund usage rules. The document is a formal opinion on specific board meeting matters, not a full financial report, earnings release, or management discussion. It is not a report publication announcement or certification letter but a detailed independent directors' opinion on board decisions. This fits best under Board/Management Information (MANG), as it relates to board meeting matters and independent directors' opinions on company decisions.
2016-03-01 Chinese
招商证券股份有限公司关于公司使用超募资金收购上海驭发制药设备有限公司40%股权的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the use of over-raised funds by Shanghai Dongfulong Technology Co., Ltd. to acquire a 40% equity stake in Shanghai Yufa Pharmaceutical Equipment Co., Ltd. It includes detailed information about the fundraising, use of funds, investment details, company background, and compliance with regulatory requirements. The document is not a general financial report, earnings release, or management discussion but rather a specific audit or verification report related to the use of funds and compliance with regulations. It is not an announcement of a report but the report itself, given the detailed content and length (4226 characters). The nature of the document aligns with an Audit Report / Information (AR) as it involves verification and compliance checking by the sponsoring institution. FY 2016
2016-03-01 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.